Novo Nordisk diabetes drug works; no heart risk-FDA review Ruby Khatun Khatun18 Oct 2017 9:40 AM ISTNovo Nordisk A/S’s closely watched diabetes drug semaglutide is effective, caused no heart risk, and carried the only limited risk of sight problems,...
US judge in Texas invalidates Allergan patents on Restasis Ruby Khatun Khatun18 Oct 2017 9:15 AM ISTA U.S. judge on Monday invalidated patents on Allergan Plc’s dry-eye medicine Restasis on grounds that the patents cover ideas that are obvious,...
Nurses cannot Dispense Medicines: High court turns Government order Ruby Khatun Khatun17 Oct 2017 1:28 PM ISTKOCHI: Giving their decision on the petition filed by M Sabira regarding the distribution of medicines through unqualified pharmacists, Kerala High...
Glenmark gets USFDA nod for Aprepitant capsules Ruby Khatun Khatun17 Oct 2017 10:17 AM ISTNew Delhi: Glenmark Pharmaceuticals said its US-based arm has received final approval from the US FDA for Aprepitant capsules, used for preventing...
Zydus Cadila gets USFDA nod to market Allopurinol tablets Ruby Khatun Khatun17 Oct 2017 10:03 AM ISTNew Delhi: Drug firm Zydus Cadila on Saturday said it has received final approval from the US health regulator to market Allopurinol tablets used for...
Roches Alecensa wins EU panels nod against mutated lung cancer Ruby Khatun Khatun17 Oct 2017 9:37 AM ISTZURICH: Swiss drugmaker Roche’s Alecensa has been recommended for approval in Europe as a first-line treatment for mutated lung cancer, a key European...
Regeneron, Sanofi drug succeeds mid-stage study Ruby Khatun Khatun17 Oct 2017 9:15 AM ISTRegeneron Pharmaceuticals Inc and Sanofi SA said on Monday their drug to treat inflammation in the esophagus, mainly caused by food allergies, met the...
Pharma companies may post better results in Q2 on local biz growth Ruby Khatun Khatun16 Oct 2017 10:31 AM ISTMumbai: Indian pharmaceutical companies are expected to post better results in the second quarter of the current fiscal, following the recovery in the...
Zydus Cadila gets USFDA nod to market Doxazosin tablets Ruby Khatun Khatun16 Oct 2017 10:24 AM ISTNew Delhi: Zydus Cadila has received approval from the US health regulator to market Doxazosin tablets, used for the treatment of high blood pressure...
GlaxoSmithKline shingles vaccine gets approval in Canada Ruby Khatun Khatun16 Oct 2017 9:48 AM ISTCanadian health regulators have approved GlaxoSmithKline’s key shingles vaccine, the company said on Friday.Shingrix, the British pharma company’s...
Merck says will not seek approval of cholesterol treatment Ruby Khatun Khatun16 Oct 2017 9:23 AM ISTMerck & Co Inc said on Wednesday it will not seek regulatory approval for its experimental cholesterol drug, anacetrapib, as the clinical profile...
Lupin launches pain relieving tablets in US Ruby Khatun Khatun15 Oct 2017 11:35 AM ISTNew Delhi: Drug firm Lupin said it has launched its pain relieving Hydrocodone Bitartrate and Acetaminophen tablets in the American market.The company...
